Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Design and development of high clearance e-vehicle for robotic cotton picker.

Scientific reports·2026
Same author

A bacteriophytochrome Pr/Pfr heterodimer studied through single-particle time-resolved cryo-electron microscopy.

Communications chemistry·2026
Same author

Comparing the Efficacy Between Entry-Level Torsional and High-End Transverse Phacoemulsification Technologies.

Cureus·2026
Same author

Usability and accuracy of a cloud-based sizing software for left atrial appendage closure.

REC, interventional cardiology·2026
Same author

Advancing protein engineering via organic chemistry.

Communications chemistry·2026
Same author

Computer Vision-Assisted Measurement of Ephemeral Gully Morphology Using a Portable Pin-Artboard Sensor.

Sensors (Basel, Switzerland)·2026
Same journal

Relationship between Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and the Risk of COVID-19: A Meta-Analysis.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2023
Same journal

Timing Matters: Effects of Early and Late Estrogen Replacement Therapy on Glucose Metabolism and Vascular Reactivity in Ovariectomized Aged Wistar Rats.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2023
Same journal

Genetic Variants Associated with High Susceptibility of Premature Ischemic Stroke.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2023
Same journal

Renin Trajectories and Outcome in Stable Heart Failure with Reduced Ejection Fraction (HFrEF) on Contemporary Therapy: A Monocentric Study from an Austrian Tertiary Hospital Outpatient Clinic.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2023
Same journal

New Viral Diseases and New Possible Remedies by Means of the Pharmacology of the Renin-Angiotensin System.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2023
Same journal

Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2023
See all related articles

Related Experiment Video

Updated: Jun 26, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

Experimental models for nephropathy.

Pitchal Balakumar1, Vishal Arvind Chakkarwar, Vijay Kumar

  • 1Cardiovascular Pharmacology Division, ISF College of Pharmacy, Institute of Pharmaceutical Sciences and Drug Research, Moga, India. pbala2006@gmail.com

Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|January 8, 2009
PubMed
Summary
This summary is machine-generated.

Nephropathy, a growing health concern, involves kidney damage and declining function. This review explores animal models to understand disease mechanisms and develop new therapies for nephropathy.

More Related Videos

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Related Experiment Videos

Last Updated: Jun 26, 2026

Assessment of Kidney Function in Mouse Models of Glomerular Disease
09:16

Assessment of Kidney Function in Mouse Models of Glomerular Disease

Published on: June 30, 2018

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Area of Science:

  • Nephrology
  • Pathophysiology
  • Pharmacology

Background:

  • Nephropathy is a major cause of illness and death, with increasing prevalence in industrialized countries.
  • Characterized by nodular glomerulosclerosis, glomerular basement membrane thickening, and mesangial expansion, leading to reduced glomerular filtration rate, albuminuria, hypertension, and fluid retention.
  • Hyperglycemia, hyperlipidemia, and hypertension are key risk factors driving nephropathy progression.

Purpose of the Study:

  • To review various animal models used in nephropathy research.
  • To enhance understanding of nephropathy pathogenesis.
  • To identify potential avenues for developing novel nephropathy therapeutics.

Main Methods:

  • Review of existing literature on animal models for nephropathy.
  • Analysis of signaling pathways implicated in nephropathy.
  • Discussion of the utility of animal models in drug discovery for nephropathy.

Main Results:

  • Several signaling systems, including vasoconstrictor peptides, inflammatory mediators, growth factors, and adhesion molecules, are involved in nephropathy pathogenesis.
  • Current therapeutic options for nephropathy are limited due to incomplete understanding of its underlying mechanisms.
  • Animal models offer a platform for studying disease progression and testing potential treatments.

Conclusions:

  • A deeper understanding of nephropathy pathogenesis is crucial for developing effective treatments.
  • Various animal models are instrumental in elucidating disease mechanisms and facilitating drug development for nephropathy.
  • Further research utilizing these models may lead to promising new therapies for nephropathy.